Once-daily budesonide inhalation suspension for the treatment of persistent asthma in infants and young children

Annals of Allergy, Asthma and Immunology

Volumn 83, Issue 3, 1999, Pages 231-239

  Kemp, James P ^a   Skoner, David P ^b   Szefler, Stanley J ^c   Walton Bowen, Karen ^d   Cruz Rivera, Mario ^d   Smith, Joseph A ^d  

^a ALLERGY AND ASTHMA MEDICAL GROUP AND RESEARCH CENTER   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^c NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^d ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHODILATING AGENT; BUDESONIDE; CORTICOTROPIN; HYDROCORTISONE; SALBUTAMOL; TETRACOSACTIDE;

ARTICLE; ASTHMA; BRONCHOSPASM; CELLULITIS; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INFANT; INHALATIONAL DRUG ADMINISTRATION; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEBULIZER; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINUSITIS;

EID: 0032828127     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)62646-4     Document Type: Article

References (36)

1. Åberg N, Hesselmar B, Åberg B, Eriksson B. Increase of asthma, allergic rhinitis and eczema in Swedish schoolchildren between 1979 and 1991. Clin Exp Allergy 1995;25: 815-819.
2. Centers for Disease Control and Prevention. Asthma mortality and hospitalization among children and young adults - United States, 1980-1993. MMWR 1996;45:350-353.
3. Friday GA, Fireman P. Morbidity and mortality of asthma. Pediatr Clin North Am 1988;35:1149-1162.
4. Burr ML, Butland BK, King S, Vaughan-Williams E. Changes in asthma prevalence: two surveys 15 years apart. Arch Dis Child 1989;64: 1452-1456.
5. Centers for Disease Control and Prevention. Asthma-United States, 1982-1992. MMWR 1995;43: 952-955.
6. National Heart, Lung and Blood Institute, National Institutes of Health. National Asthma Education Program Expert Panel Report. Guidelines for the diagnosis and management of asthma. Expert panel report no. 2. Bethesda, MD: National Institutes of Health, 1997 (NIH publication no. 97-4051).
7. Bisgaard H, Munck SL, Nielsen JP, et al. Inhaled budesonide for treatment of recurrent wheezing in early childhood. Lancet 1990;336:649-651.
8. Connett GJ, Warde C, Wooler E, Lenney W. Use of budesonide in severe asthmatics aged 1-3 years. Arch Dis Child 1993;69:351-355.
9. Noble V, Ruggins NR, Everard ML, Milner AD. Inhaled budesonide for chronic wheezing under 18 months of age. Arch Dis Child 1992;67:285-288.
10. Eseverri J-L, Botey J, Marin A-M. Budesonide: treatment of bronchial asthma during childhood. Allergie Immunol 1995;27:129-135.
11. Gleeson JGA, Price JF. Controlled trial of budesonide given by the Nebuhaler in preschool children with asthma. BMJ 1988;297:163-166.
12. Pedersen S, Hansen OR. Budesonide treatment of moderate and severe asthma in children: a dose-response study. J Allergy Clin Immunol 1995; 95:29-33.
13. Foucard T. Aggressive treatment of childhood asthma with local steroids. Good or bad? Allergy 1996;51: 367-371.
14. Godfrey S, Avital A, Rosler A, et al. Nebulised budesonide in severe infantile asthma [letter]. Lancet 1987;ii: 851-852.
15. Grimfeld A, Lesbros D, Ostinelli J, Caswell C. Long-term study of nebulised budesonide in young children with moderate to severe asthma [abstract]. Eur Respir J 1994;7(Suppl 18): 27S.
16. Ilangovan P, Pedersen S, Godfrey S, et al. Treatment of severe steroid-dependent preschool asthma with nebulised budesonide suspension. Arch Dis Child 1993;68:356-359.
17. Pedersen S, Ramsgaard-Hansen O, Nikander K. Budesonide suspension for nebulisation in children with asthma [abstract]. Eur Respir J 1989;2(Suppl 8):647S.
18. Vikre-Jørgensen J, Agertoft L, Pedersen S. Dose titration of nebulized budesonide in young children. Pediatr Pulmonol 1997;23:270-277.
19. Volovitz B, Soferman R, Blau H, et al. Rapid induction of clinical response with a short-term high-dose starting schedule of budesonide nebulizing suspension in young children with recurrent wheezing episodes. J Allergy Clin Immunol 1998;101:464-469.
20. Wennergren G, Nordvall SL, Hedlin G, et al. Nebulized budesonide for the treatment of moderate to severe asthma in infants and toddlers. Acta Paediatr 1996;85:183-189.
21. National Heart, Lung and Blood Institute, National Institutes of Health. National Asthma Education Program Expert Panel Report. Guidelines for the diagnosis and management of asthma. Bethesda, MD: National Institutes of Health, 1992 (NIH publication no. 91-3042).
22. de Blic J, Delacourt C, Le Bourgeois M, et al. Efficacy of nebulized budesonide in treatment of severe infantile asthma: a double-blind study. J Allergy Clin Immunol 1996;98:14-20.
23. Pedersen S, O'Byrne P. A comparison of the efficacy and safety of inhaled corticosteroids in asthma. Allergy 1997;52(Suppl 39):1-34.
24. Shapiro G, Bronsky EA, LaForce CF, et al. Dose-related efficacy of budesonide administered via a dry powder inhaler in the treatment of children with moderate to severe persistent asthma. J Pediatr 1998;132:976-982.
25. Agertoft L, Pedersen S. Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children. Respir Med 1994;88:373-381.
26. Cogswell JJ, Simpkiss MJ. Nebulised sodium cromoglycate in recurrently wheezy preschool children. Arch Dis Child 1985;60:736-738.
27. Furukawa CT, Shapiro GG, Bierman CW, et al. A double-blind study comparing the effectiveness of cromolyn sodium and sustained-release theophylline in childhood asthma. Pediatrics 1984;74:453-459.
28. Selcow JE, Mendelson LM, Rosen JP. Clinical benefits of cromolyn sodium aerosol (MDI) in the treatment of asthma in children. Ann Allergy 1989; 62:195-199.
29. Bertelsen A, Andersen JB, Busch P, et al. Nebulised sodium cromoglycate in the treatment of wheezy bronchitis. Allergy 1986;41:266-270.
30. Tasche MJA, van der Wouden JC, Uijen JHJM, et al. Randomised placebo-controlled trial of inhaled sodium cromoglycate in 1-4-year-old children with moderate asthma. Lancet 1997; 350:1060-1064.
31. Furfaro S, Spier S, Drblik S, et al. Efficacy of cromoglycate in persistently wheezing infants. Arch Dis Child 1994;71:331-334.
32. Östergaard PA, Pedersen S. The effect of inhaled disodium cromoglycate and budesonide on bronchial responsiveness to histamine and exercise in asthmatic children: a clinical comparison. In: Godfrey S, editor. Glucocorticosteroids in Childhood Asthma. Budapest: XIII Congress of the European Academy of Allergology and Clinical Immunology (EAACI); 1986. p. 55-65.
33. Verberne AAPH, Frost C, Roorda RJ, et al. One year treatment with salmeterol compared with beclomethasone in children with asthma. Am J Respir Crit Care Med 1997;156:688-695.
34. van Essen-Zandvliet EE, Hughes MD, Waalkens HJ, et al. Effects of 22 months of treatment with inhaled corticosteroids and/or beta-2-agonists on lung function, airway responsiveness, and symptoms in children with asthma. Am Rev Respir Dis 1992;146: 547-554.
35. Bisgaard H, Nikander K, Munch E. Comparative study of budesonide as a nebulized suspension vs pressurized metered-dose inhaler in adult asthmatics. Respir Med 1998;92:44-49.
36. Busse WW, Chervinsky P, Condemi J, et al. Budesonide delivered by Turbuhaler is effective in a dose-dependent fashion when used in the treatment of adult patients with chronic asthma. J Allergy Clin Immunol 1998;101: 475-463.